Science and Research IGM Biosciences slides by 66% on discontinued drug development and lay offs The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis Rowan DunneJanuary 10, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
Medical and Pharmaceutical Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment Rowan DunneJanuary 7, 2025
Medical and Pharmaceutical RAPT Therapeutics sees 113% spike on allergy med licensing deal & private placement The biotech operator can develop and commercialize Jemincare's food allergy medication throughout most of the world Rowan DunneDecember 23, 2024
Cannabis Weedmaps parent company stock spikes after proposition to go private The multi-purpose cannabis platform operator has been on a steady decline since it went public in 2021 Rowan DunneDecember 18, 2024
Technology Video & AI specialist Maris-Tech surges on release of ‘Uranus-Drones’ system The Israeli technology company has secured a purchase order of 100 units to be shipped by year-end Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Technology Sidus Space heads for the stars with 220% spike, but why? Some investors have speculated that a short squeeze might be the main cause Rowan DunneDecember 16, 2024
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024
Stock News Nasdaq Composite hits 20K points on big tech rally, Trump enthusiasm Its rise is being propelled by continued gains among major stocks like Alphabet, Tesla and NVIDIA Rowan DunneDecember 11, 2024